US stocks saw mixed results Thursday as a combination of the uncertainty surrounding the healthcare debate weighed on overall performance of the sector, and a downgrade of Biogen by Morgan Stanley and Leerink sent the stock tanking 5.1%. Several different sectors dropped into the red throughout the day, with healthcare leading the ray, touching 1% in the red at different times.